Search Results - "Buyukbayram, Mehmet Emin"

A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR) by Buyukbayram, Mehmet Emin, Hannarici, Zekeriya, Turhan, Aykut, Caglar, Alperen Akansel, Esdur, Pınar Çoban, Bilici, Mehmet, Tekin, Salim Basol, Erdemci, Burak

“…Cervical cancer is a tumor with high morbidity and mortality. The importance of inflammatory and metabolic parameters affecting progression-free survival (PFS)…”
Get full text

Lipegfilgrastim may cause hyperleukocytosis by Hannarici, Zekeriya, Yılmaz, Ali, Buyukbayram, Mehmet Emin, Turhan, Aykut, Tekin, Salim Başol, Bilici, Mehmet

“…Introduction Granulocyte colony-stimulating factors (G-CSF) are utilized both in the treatment and prophylaxis of chemotherapy-induced neutropenia…”
Get full text

Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma by Aykut Turhan, Zekeriya Hannarici, Mehmet Emin Büyükbayram, Alperen Akansel Çağlar, Pınar Çoban Eşdur, Mehmet Bilici, Salim Başol Tekin

Get full text

The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer by Hannarici, Zekeriya, Yılmaz, Ali, Buyukbayram, Mehmet Emin, Turhan, Aykut, Çağlar, Alperen Akansel, Bilici, Mehmet, Tekin, Salim Başol

“…To demonstrate the prognostic importance of glucose-to-lymphocyte ratio (GLR) in metastatic gastric cancer (mGC). Retrospectively, 159 mGC patients were…”
Get full text

The Effect of C-Reactive Protein/Lymphocyte Ratio by Caglar, Alperen Akansel, Hannarici, Zekeriya, Yazilitas, Dogan, Turhan, Aykut, Tekin, Salim Basol, Buyukbayram, Mehmet Emin, Bilici, Mehmet, Duzkopru, Yakup, Esdur, Pinar Coban

“…Objective: Hormone positive breast cancer is a tumor with high mortality. Combining antihormonal therapy with cyclin dependent kinase 4/6 inhibitors (CDK4/6i)…”
Get full text

Inflammatory parameters in NSCLC with driver mutation by Buyukbayram, Mehmet Emin, Hannarici, Zekeriya, Yilmaz, Ali, Turhan, Aykut, Caglar, Alperen Akansel, Esdur, Pınar Coban, Bilici, Mehmet, Tekin, Salim Basol

“…The tumor microenvironment of NSCLC with driver mutations, such as , and , is less inflammatory. This retrospective study included 38 patients with NSCLC…”
Get full text

The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker by Buyukbayram, Mehmet Emin, Hannarici, Zekeriya, Duzkopru, Yakup, Turhan, Aykut, Caglar, Alperen Akansel, Coban Esdur, Pınar, Bilici, Mehmet, Tekin, Salim Basol, Yazılıtaş, Doğan

“…Hormone positive breast cancer is a tumor with high mortality. Combining antihormonal therapy with cyclin dependent kinase 4/6 inhibitors (CDK4/6i) has…”
Get full text